Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Daniel Pratt
daniel.pratt@manchester.ac.uk


Ms Matina Shafti
Matina.shafti@manchester.ac.uk


Study Location:

Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - COSAF

COSAF

Completed

Open to: Female / Male

Age: 18 Years - N/A

Medical Conditions

Intentional self-harm


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Dual-harm is the co-occurrence of self-harm and aggression in an individual throughout the course of their lifetime. This harmful behaviour is especially prevalent amongst forensic mental health service users and can lead to health and social problems. It is important to identify why these individuals may engage in dual-harm to help us prevent and reduce this harmful behaviour. Psychopathy is an antisocial personality style which is more prevalent in forensic populations than the general population, and is linked to self-harm and aggression. Those with psychopathy personality styles have been found to have impairments in regulating their emotions (referred to as emotional dysregulation) and such impairments are linked to harmful behaviours. It may be that those with psychopathy personality styles are more likely to engage in dual-harm as a way to regulate their negative emotions. However, no previous study has examined this hypothesis. Therefore, this study aims to extend our understanding of dual-harm by investigating whether psychopathy and emotional dysregulation play a role in dual-harm amongst forensic mental health service users. This project will use quantitative (cross-sectional and longitudinal) and qualitative designs. Participants with a history of dual-harm will be recruited from secure mental health services in England. For the quantitative study, participants will answer questionnaires assessing their personality, emotional dysregulation and dual-harm thoughts/behaviours at two different time points. For the qualitative study, semi-structured interviews will be conducted to explore how participants perceive their personality and emotional regulation to contribute to their dual-harm. Findings may inform future research of dual-harm and have important implications for clinical services. This study can help identify potential key mechanisms of dual-harm that can be targeted in strategies aiming to reduce and prevent self-harm and aggression.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

11 Jun 2021 17 May 2023

Observational

Observational type: Cross-sectional;



You can take part if:



You may not be able to take part if:


• Individuals who have been deemed by the clinical staff to pose too great a risk to the safety of the researcher or to themselves • Has any of the Covid-19 symptoms


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Lantern Centre
    Vicarage Lane
    fulwood
    Preston
    Lancashire
    PR2 8DW
  • Gmw Trust Headquarters
    Prestwich Site
    bury New Road
    prestwich
    Manchester
    Greater Manchester
    M25 3BL


The study is sponsored by University of Manchester and funded by Economic and Social Research Council (ESRC) .




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details

for Trial ID: CPMS 50277

Last updated 25 September 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.